| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61680-0.025ml | |||
| Conjugate | Catalog # | Availability | Size | Price |
|---|---|---|---|---|
| Biotin | NBP1-26668 | |||
| FITC | NBP1-26667 | |||
| PE | NBP1-26669 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61811-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61791-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52706-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52644-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-61893-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP1-97446-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-11969SS | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12182-0.025mg | |||
![Western Blot: CCR7 Antibody (4B7B8) [NBP2-61680] - Analysis using CD197 mAb against HEK293 (1) and CD197 (AA: extra mix)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/CCR7-Antibody-4B7B8-Western-Blot-NBP2-61680-img0004.jpg "Western Blot: CCR7 Antibody (4B7B8) [NBP2-61680] - Analysis using CD197 mAb against HEK293 (1) and CD197 (AA: extra mix)-hIgGFc transfected HEK293 (2) cell lysate.")
![Flow Cytometry: CCR7 Antibody (4B7B8) [NBP2-61680] - Analysis of K562 cells using CCR7 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CCR7-Antibody-4B7B8-Flow-Cytometry-NBP2-61680-img0006.jpg)
![Western Blot: CCR7 Antibody (4B7B8) [NBP2-61680] - Analysis using CD197 mAb against human CD197 (AA: extra mix) recombinant protein. (Expected MW is 37.5 kDa)](http://images.novusbio.com/fullsize/CCR7-Antibody-4B7B8-Western-Blot-NBP2-61680-img0003.jpg)
![Western Blot: CCR7 Antibody (4B7B8) [NBP2-61680] - Analysis using CD197 mouse mAb against C6 (1) cell lysate.](http://images.novusbio.com/fullsize/CCR7-Antibody-4B7B8-Western-Blot-NBP2-61680-img0005.jpg)
![Flow Cytometry: CCR7 Antibody (4B7B8) [NBP2-61680] - Analysis of HL-60 cells using CCR7 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CCR7-Antibody-4B7B8-Flow-Cytometry-NBP2-61680-img0002.jpg)
![ELISA: CCR7 Antibody (4B7B8) [NBP2-61680] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/CCR7-Antibody-4B7B8-ELISA-NBP2-61680-img0001.jpg)
![Flow Cytometry: CD2 Antibody (12-15) [NBP1-26666] - BALB/c mouse splenocytes were stained with Rat Anti-Mouse CD2-UNLBfollowed by Mouse Anti-Rat IgG1-FITC.](http://images.novusbio.com/fullsize/CD2-Antibody-12-15-Flow-Cytometry-NBP1-26666-img0009.jpg "Flow Cytometry: CD2 Antibody (12-15) [NBP1-26666] - BALB/c mouse splenocytes were stained with Rat Anti-Mouse CD2-UNLBfollowed by Mouse Anti-Rat IgG1-FITC.")
![Flow Cytometry: CD2 Antibody (12-15) [NBP1-26666] - Analysis using the Biotin conjugate of NBP1-26666. Multiple staining of C57BL/6 splenocytes.](http://images.novusbio.com/fullsize/CD2-Antibody-12-15-Flow-Cytometry-NBP1-26666-img0003.jpg)
![Flow Cytometry: CD2 Antibody (12-15) [NBP1-26666] - Analysis using the FITC conjugate of NBP1-26666. Staining of 1 ug/1^6 BALB/c lymph node cells with rat anti-mouse CD2-FITC. Lymphocytes were then gated and analyzed by flow cytometry.](http://images.novusbio.com/fullsize/CD2-Antibody-12-15-Flow-Cytometry-NBP1-26666-img0004.jpg)
![Flow Cytometry: CD2 Antibody (12-15) [NBP1-26666] - Analysis using the FITC conjugate of NBP1-26666. Staining of C57BL/6 mouse splenocytes with NBP1-26669 (PE conjugate) and NBP1-26667 (FITC conjugate).](http://images.novusbio.com/fullsize/CD2-Antibody-12-15-Flow-Cytometry-NBP1-26666-img0005.jpg)
![Flow Cytometry: CD2 Antibody (12-15) [NBP1-26666] - BALB/c mouse splenocytes were stained with Rat Anti-Mouse CD2-FITC (NBP1-26667).](http://images.novusbio.com/fullsize/CD2-Antibody-12-15-Flow-Cytometry-NBP1-26666-img0008.jpg)
![Western Blot: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Analysis using KIR3DL1 mAb against human KIR3DL1 (AA: extra 22-340) recombinant protein. (Expected MW is 65 kDa)](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9F6-Western-Blot-NBP2-61811-img0003.jpg "Western Blot: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Analysis using KIR3DL1 mAb against human KIR3DL1 (AA: extra 22-340) recombinant protein. (Expected MW is 65 kDa)")
![Immunohistochemistry: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Analysis of paraffin-embedded cervical cancer tissues using KIR3DL1 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9F6-Immunohistochemistry-NBP2-61811-img0002.jpg)
![Western Blot: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Analysis using KIR3DL1 mouse mAb against A431 (1), Raji (2), SPC-A-1 (3), K562 (4), HEK293 (5), U937 (6), C6 (7), and COS7 (8) cell lysate.](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9F6-Western-Blot-NBP2-61811-img0004.jpg)
![ELISA: KIR3DL1 Antibody (6D9F6) [NBP2-61811] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/KIR3DL1-Antibody-6D9F6-ELISA-NBP2-61811-img0001.jpg)
![Western Blot: Plexin A1 Antibody (8A10A6) [NBP2-61791] - Analysis using PLXNA1 mAb against human PLXNA1 (AA: 1100-1200) recombinant protein. (Expected MW is 36.8 kDa)](http://images.novusbio.com/fullsize/Plexin-A1-Antibody-8A10A6-Western-Blot-NBP2-61791-img0004.jpg "Western Blot: Plexin A1 Antibody (8A10A6) [NBP2-61791] - Analysis using PLXNA1 mAb against human PLXNA1 (AA: 1100-1200) recombinant protein. (Expected MW is 36.8 kDa)")
![Immunocytochemistry/Immunofluorescence: Plexin A1 Antibody (8A10A6) [NBP2-61791] - Analysis of Hela cells using PLXNA1 mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Goat anti-Mouse IgG (H+L) DyLight 488 secondary antibody was used.](http://images.novusbio.com/fullsize/Plexin-A1-Antibody-8A10A6-Immunocytochemistry-Immunofluorescence-NBP2-61791-img0003.jpg)
![Flow Cytometry: Plexin A1 Antibody (8A10A6) [NBP2-61791] - Analysis of Hela cells using PLXNA1 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/Plexin-A1-Antibody-8A10A6-ELISA-NBP2-61791-img0002.jpg)
![Western Blot: Plexin A1 Antibody (8A10A6) [NBP2-61791] - Analysis using PLXNA1 mAb against HEK293 (1) and PLXNA1 (AA: 1100-1200)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/Plexin-A1-Antibody-8A10A6-Western-Blot-NBP2-61791-img0005.jpg)
![ELISA: Plexin A1 Antibody (8A10A6) [NBP2-61791] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/Plexin-A1-Antibody-8A10A6-ELISA-NBP2-61791-img0001.jpg)
![Immunohistochemistry: CD4 Antibody (MT310) [NBP2-52706] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The mouse IgG1-chimeric version of MT310 (NBP2-52706) was used to stain samples at a concentration of 3 ug/ml.](http://images.novusbio.com/fullsize/CD4-Antibody-MT310-Immunohistochemistry-NBP2-52706-img0001.jpg "Immunohistochemistry: CD4 Antibody (MT310) [NBP2-52706] - Anti-CD4 staining of formaldehyde fixed paraffin embedded guinea pig skin tissue, at 40x magnification. The mouse IgG1-chimeric version of MT310 (NBP2-52706) was used to stain samples at a concentration of 3 ug/ml.")
![Western Blot: SYK Antibody (2G11E6) [NBP2-61893] - Analysis using SYK mAb against human SYK (AA: 217-356) recombinant protein. (Expected MW is 41.4 kDa)](http://images.novusbio.com/fullsize/SYK-Antibody-2G11E6-Western-Blot-NBP2-61893-img0004.jpg "Western Blot: SYK Antibody (2G11E6) [NBP2-61893] - Analysis using SYK mAb against human SYK (AA: 217-356) recombinant protein. (Expected MW is 41.4 kDa)")
![Immunocytochemistry/Immunofluorescence: SYK Antibody (2G11E6) [NBP2-61893] - Analysis of Hela cells using SYK mouse mAb (green). Blue: DRAQ5 fluorescent DNA dye. Red: Actin filaments have been labeled with Alexa Fluor- 555 phalloidin. Goat anti-Mouse IgG (H+L) DyLight 488 secondary antibody was used.](http://images.novusbio.com/fullsize/SYK-Antibody-2G11E6-Immunocytochemistry-Immunofluorescence-NBP2-61893-img0003.jpg)
![Flow Cytometry: SYK Antibody (2G11E6) [NBP2-61893] - Analysis of Hela cells using SYK mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/SYK-Antibody-2G11E6-Flow-Cytometry-NBP2-61893-img0002.jpg)
![Western Blot: SYK Antibody (2G11E6) [NBP2-61893] - Analysis using SYK mAb against HEK293 (1) and SYK (AA: 217-356)-hIgGFc transfected HEK293 (2) cell lysate.](http://images.novusbio.com/fullsize/SYK-Antibody-2G11E6-Western-Blot-NBP2-61893-img0005.jpg)
![ELISA: SYK Antibody (2G11E6) [NBP2-61893] - Black line: Control Antigen (100 ng);Purple line: Antigen (10ng); Blue line: Antigen (50 ng); Red line:Antigen (100 ng)](http://images.novusbio.com/fullsize/SYK-Antibody-2G11E6-ELISA-NBP2-61893-img0001.jpg)
![Western Blot: CD163 Antibody (OTI2B12) - Azide and BSA Free [NBP2-71420] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD163.](http://images.novusbio.com/fullsize/CD163-Antibody-OTI2B12-Azide-and-BSA-Free-Western-Blot-NBP2-71420-img0002.jpg "Western Blot: CD163 Antibody (OTI2B12) - Azide and BSA Free [NBP2-71420] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY CD163.")
![Immunocytochemistry/Immunofluorescence: CD163 Antibody (OTI2B12) - Azide and BSA Free [NBP2-71420] - Analysis of COS7 cells transiently transfected by pCMV6-ENTRY CD163.](http://images.novusbio.com/fullsize/CD163-Antibody-OTI2B12-Azide-and-BSA-Free-Immunocytochemistry-Immunofluorescence-NBP2-71420-img0004.jpg)
![Immunohistochemistry: CD163 Antibody (OTI2B12) - Azide and BSA Free [NBP2-71420] - Analysis of Human liver tissue. (Heat-induced epitope retrieval by 10mM citric buffer, pH6.0, 120C for 3min)](http://images.novusbio.com/fullsize/CD163-Antibody-OTI2B12-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71420-img0003.jpg)
![Western Blot: CD163 Antibody (OTI2B12) - Azide and BSA Free [NBP2-71420] - Analysis of extracts (35ug) from 9 different cell lines by using CD163 monoclonal antibody (HepG2: human; HeLa: human; SVT2: mouse; A549: human; COS7: monkey; Jurkat: human; MDCK: canine; PC12: rat; MCF7: human).](http://images.novusbio.com/fullsize/CD163-Antibody-OTI2B12-Azide-and-BSA-Free-Western-Blot-NBP2-71420-img0001.jpg)
![Western Blot: LAG-3 Antibody (OTI8F6) [NBP2-71112] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LAG3.](http://images.novusbio.com/fullsize/LAG-3-Antibody-OTI8F6-Azide-and-BSA-Free-Western-Blot-NBP2-71112-img0001.jpg "Western Blot: LAG-3 Antibody (OTI8F6) [NBP2-71112] - Analysis of HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY LAG3.")
![Immunohistochemistry: LAG-3 Antibody (OTI8F6) - Azide and BSA Free [NBP2-71112] - Analysis of Adenocarcinoma of Human colon tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)(1:150)](http://images.novusbio.com/fullsize/LAG-3-Antibody-OTI8F6-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71112-img0003.jpg)
![Flow Cytometry: LAG-3 Antibody (OTI8F6) - Azide and BSA Free [NBP2-71112] - Analysis of living PBMCs treated with 10ug/ml PHA for 72h (Right)/untreated (Left) using anti-LAG3 antibody (1:100).](http://images.novusbio.com/fullsize/LAG-3-Antibody-OTI8F6-Azide-and-BSA-Free-Flow-Cytometry-NBP2-71112-img0002.jpg)
![Immunohistochemistry: LAG-3 Antibody (OTI8F6) - Azide and BSA Free [NBP2-71112] - Analysis of Adenocarcinoma of Human ovary tissue. (Heat-induced epitope retrieval by Tris-EDTA, pH8.0)(1:150)](http://images.novusbio.com/fullsize/LAG-3-Antibody-OTI8F6-Azide-and-BSA-Free-Immunohistochemistry-NBP2-71112-img0004.jpg)
![Flow Cytometry: OX40 Ligand/TNFSF4 Antibody (MM0505-8S23) [NBP2-11969] - An intracellular stain was performed on U-937 cells withOX40 Ligand/TNFSF4 Antibody (MM0505-8S23) NBP2-11969PE (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Phycoerythrin.](http://images.novusbio.com/fullsize/OX40-Ligand-TNFSF4-Antibody-MM0505-8S23-Flow-Cytometry-NBP2-11969-img0001.jpg "Flow Cytometry: OX40 Ligand/TNFSF4 Antibody (MM0505-8S23) [NBP2-11969] - An intracellular stain was performed on U-937 cells withOX40 Ligand/TNFSF4 Antibody (MM0505-8S23) NBP2-11969PE (blue) and a matched isotype control (orange). Cells were fixed with 4% PFA and then permeabilized with 0.1% saponin. Cells were incubated in an antibody dilution of 5 ug/mL for 30 minutes at room temperature. Both antibodies were conjugated to Phycoerythrin.")
![Immunohistochemistry-Paraffin: CD86 Antibody (AP-MAB0803) [NBP2-12182] - 4% PFA fixed and paraffin embedded mouse lung tissue (LPS treated) was subjected to IHC staining using this CD86](http://images.novusbio.com/fullsize/CD86-Antibody-AP-MAB0803-Immunohistochemistry-Paraffin-NBP2-12182-img0001.jpg "Immunohistochemistry-Paraffin: CD86 Antibody (AP-MAB0803) [NBP2-12182] - 4% PFA fixed and paraffin embedded mouse lung tissue (LPS treated) was subjected to IHC staining using this CD86")